Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Gauthier

Showing results (141-150 of 422) with videos related to

Pageof 43
Sort By:
Current Alzheimer Research|October 3, 2007
Alzhemed: a potential treatment for Alzheimer's diseasePaul S Aisen, Serge Gauthier, Bruno Vellas, et al.
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement|October 19, 2023
Latest Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: What's in It for Primary Care?Laura Rojas-Rozo, Linda Lee, Vladimir Khanassov, et al.
Trends in Molecular Medicine|June 18, 2022
Staging of Alzheimer's disease: past, present, and future perspectivesJoseph Therriault, Eduardo R Zimmer, Andrea L Benedet, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 5, 2023
Health System Change for Alzheimer's Disease-Modifying Therapies in Canada: Beginning the DiscussionAndrew Frank, Zahinoor Ismail, Melanie Wilson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 1, 2021
A quadratic function of activation in individuals at risk of Alzheimer's diseaseNick Corriveau-Lecavalier, Simon Duchesne, Serge Gauthier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 29, 2015
Why has therapy development for dementia failed in the last two decades?Serge Gauthier, Marilyn Albert, Nick Fox, et al.
International Journal of Geriatric Psychiatry|April 12, 2012
Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical studyVjera Holthoff, Steven Ferris, Serge Gauthier, et al.
International Psychogeriatrics|April 3, 2003
Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's diseaseSerge Gauthier, Howard Feldman, Jane Hecker, et al.
Fundamental & Clinical Pharmacology|August 14, 2003
Alzheimer's disease: the pharmacological pathwayHervé Allain, Danièle Bentué-Ferrer, Olivier Tribut, et al.
International Journal of Geriatric Psychiatry|May 28, 2005
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trialHoward Feldman, Serge Gauthier, Jane Hecker, et al.
Pageof 43

Showing results (141-150 of 422) with videos related to

Sort By:
Pageof 43
Current Alzheimer Research|October 3, 2007
Alzhemed: a potential treatment for Alzheimer's diseasePaul S Aisen, Serge Gauthier, Bruno Vellas, et al.
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement|October 19, 2023
Latest Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: What's in It for Primary Care?Laura Rojas-Rozo, Linda Lee, Vladimir Khanassov, et al.
Trends in Molecular Medicine|June 18, 2022
Staging of Alzheimer's disease: past, present, and future perspectivesJoseph Therriault, Eduardo R Zimmer, Andrea L Benedet, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 5, 2023
Health System Change for Alzheimer's Disease-Modifying Therapies in Canada: Beginning the DiscussionAndrew Frank, Zahinoor Ismail, Melanie Wilson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 1, 2021
A quadratic function of activation in individuals at risk of Alzheimer's diseaseNick Corriveau-Lecavalier, Simon Duchesne, Serge Gauthier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 29, 2015
Why has therapy development for dementia failed in the last two decades?Serge Gauthier, Marilyn Albert, Nick Fox, et al.
International Journal of Geriatric Psychiatry|April 12, 2012
Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical studyVjera Holthoff, Steven Ferris, Serge Gauthier, et al.
International Psychogeriatrics|April 3, 2003
Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's diseaseSerge Gauthier, Howard Feldman, Jane Hecker, et al.
Fundamental & Clinical Pharmacology|August 14, 2003
Alzheimer's disease: the pharmacological pathwayHervé Allain, Danièle Bentué-Ferrer, Olivier Tribut, et al.
International Journal of Geriatric Psychiatry|May 28, 2005
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trialHoward Feldman, Serge Gauthier, Jane Hecker, et al.
Pageof 43